Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008868
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety and efficacy of upadacitinib in
participants with active ankylosing spondylitis (AS) who have had an inadequate response to
at least 2 non-steroidal anti-inflammatory drugs (NSAIDs) or intolerance to or a
contraindication for NSAIDs, and who are naïve to biologic disease-modifying anti-rheumatic
drugs (bDMARD).
创建时间：
2025-09-15
